Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 13
2004 6
2005 8
2006 16
2007 13
2008 12
2009 9
2010 9
2011 6
2012 8
2013 11
2014 4
2015 15
2016 16
2017 13
2018 10
2019 10
2020 12
2021 19
2022 17
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
Retraction.
Tanaka K, Matsumoto Y, Nakatani F, Iwamoto Y, Yamada Y. Tanaka K, et al. Mol Cell Biol. 2009 Jun;29(12):3453. doi: 10.1128/MCB.00411-09. Mol Cell Biol. 2009. PMID: 19474393 Free PMC article. No abstract available.
Targeting glutaminase and mTOR.
Tanaka K, Sasayama T, Kohmura E. Tanaka K, et al. Oncotarget. 2015 Sep 29;6(29):26544-5. doi: 10.18632/oncotarget.5263. Oncotarget. 2015. PMID: 26337208 Free PMC article. No abstract available.
Advances in treatment of alveolar soft part sarcoma: an updated review.
Fujiwara T, Kunisada T, Nakata E, Nishida K, Yanai H, Nakamura T, Tanaka K, Ozaki T. Fujiwara T, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2023 Nov 5;53(11):1009-1018. doi: 10.1093/jjco/hyad102. Jpn J Clin Oncol. 2023. PMID: 37626447 Free PMC article. Review.
The current management of clear cell sarcoma.
Ikuta K, Nishida Y, Imagama S, Tanaka K, Ozaki T. Ikuta K, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2023 Oct 4;53(10):899-904. doi: 10.1093/jjco/hyad083. Jpn J Clin Oncol. 2023. PMID: 37451697 Review.
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
Endo M, Kataoka T, Fujiwara T, Tsukushi S, Takahashi M, Kobayashi E, Yamada Y, Tanaka T, Nezu Y, Hiraga H, Wasa J, Nagano A, Nakano K, Nakayama R, Hamada T, Kawano M, Torigoe T, Sakamoto A, Asanuma K, Morii T, Machida R, Sekino Y, Fukuda H, Oda Y, Ozaki T, Tanaka K. Endo M, et al. Among authors: tanaka k. BMC Cancer. 2023 Mar 8;23(1):219. doi: 10.1186/s12885-023-10693-w. BMC Cancer. 2023. PMID: 36890471 Free PMC article.
Slow excitotoxicity in Alzheimer's disease.
Ong WY, Tanaka K, Dawe GS, Ittner LM, Farooqui AA. Ong WY, et al. Among authors: tanaka k. J Alzheimers Dis. 2013;35(4):643-68. doi: 10.3233/JAD-121990. J Alzheimers Dis. 2013. PMID: 23481689 Review.
Effects of docosahexaenoic Acid on neurotransmission.
Tanaka K, Farooqui AA, Siddiqi NJ, Alhomida AS, Ong WY. Tanaka K, et al. Biomol Ther (Seoul). 2012 Mar;20(2):152-7. doi: 10.4062/biomolther.2012.20.2.152. Biomol Ther (Seoul). 2012. PMID: 24116288 Free PMC article. Review.
Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.
Yamasaki F, Fudaba H, Asano K, Sasayama T, Natsumeda M, Shimabukuro T, Taguchi K, Koizumi S, Nakayama N, Fujii K, Nishibuchi I, Sugiyama K, Yoshida K, Yonezawa U, Yasutomo M, Kawasaki Y, Kakuta K, Katayama K, Tanaka K, Nagashima H, Tsukamoto Y, Ideguchi M, Nishizaki T, Kurozumi K, Hosoya T, Akita T, Kambe A. Yamasaki F, et al. Among authors: tanaka k. BMJ Open. 2023 Apr 24;13(4):e071350. doi: 10.1136/bmjopen-2022-071350. BMJ Open. 2023. PMID: 37094899 Free PMC article.
238 results